![Matthew Ronsheim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Ronsheim
Verksamhetschef på
XENON PHARMACEUTICALS INC.
Profil
Matthew D.
Ronsheim is Chief Operating Officer at Xenon Pharmaceuticals, Inc. since 2024.
Formerly, Dr. Ronsheim was Executive Director & Head-Chemistry Manufacturing at Enanta Pharmaceuticals, Inc. from 2016 to 2019 and Chief Pharmaceutical Sciences Officer at Entasis Therapeutics Holdings, Inc. Education includes undergraduate studies at Southern Connecticut State University and a doctorate from the University of New Hampshire.
Aktiva positioner av Matthew Ronsheim
| Företag | Position | Start |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Verksamhetschef | 2024-08-12 |
Tidigare kända positioner av Matthew Ronsheim
| Företag | Position | Slut |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2019-08-01 |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Företagsledare/Principal | - |
Matthew Ronsheims utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
22
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Southern Connecticut State University
 Southern Connecticut State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products | Commercial Services |
